| D0008-0002 | Dasatinib | 443-89-0 | Parent API (reference standard) |
| D0008-0003 | Dasatinib | 302962-49-8 | Parent API (reference standard) |
| D0008-0004 | Dasatinib Impurity A | 302964-06-3 | Impurity |
| D0008-0017 | Dasatinib Impurity 1 | 910297-53-9 | Impurity |
| D0008-0021 | Dasatinib Impurity 2 | 910297-62-0 | Impurity |
| D0008-0022 | Dasatinib Impurity 2 | 302964-24-5 | Impurity |
| D0008-0025 | Dasatinib Impurity 3 | 1184919-23-0 | Impurity |
| D0008-0030 | Dasatinib Impurity 4 | 302964-08-5 | Impurity |
| D0008-0034 | Dasatinib Impurity 6 | 910297-51-7 | Impurity |
| D0008-0036 | Dasatinib Impurity 7 | 910297-52-8 | Impurity |
| D0008-0037 | Dasatinib Impurity 8 | 910297-57-3 | Impurity |
| D0008-0041 | Dasatinib Impurity 9 | 1159977-25-9 | Impurity |
| D0008-0042 | Dasatinib Impurity 9 | 2468737-77-9 | Impurity |
| D0008-0044 | Dasatinib Impurity 10 | 2468737-81-5 | Impurity |
| D0008-0046 | Dasatinib Impurity 11 | 1417651-54-7 | Impurity |
| D0008-0050 | Dasatinib Impurity 14 | 2468737-83-7 | Impurity |
| D0008-0055 | Dasatinib Impurity 18 | 2048106-50-7 | Impurity |
| D0008-0057 | Dasatinib Impurity 19 | 2468737-87-1 | Impurity |
| D0008-0069 | Dasatinib Impurity 29 | 2099694-52-5 | Impurity |
| D0008-0076 | Dasatinib Impurity 35 | 2167236-23-7 | Impurity |
| D0008-0080 | Dasatinib Impurity 37 | 1416737-47-7 | Impurity |
| D0008-0101 | Dasatinib Impurity 56 | 2748587-50-8 | Impurity |
| D0008-0107 | Dasatinib Impurity 62 | 6387-14-0 | Impurity |
| D0008-0108 | Dasatinib Impurity 63 | 617-07-2 | Impurity |
| D0008-0109 | Dasatinib Impurity 64 | 40686-05-3 | Impurity |
| D0008-0120 | Dasatinib Impurity 83 | 1025814-13-4 | Impurity |
| D0008-0121 | Dasatinib Impurity 84 | 1044209-24-6 | Impurity |
| D0008-0122 | Dasatinib Impurity 85 | 755031-80-2 | Impurity |
| D0008-0123 | Dasatinib Impurity 86 | 103-76-4 | Impurity |
| D0008-0125 | Dasatinib Impurity 88 | 223580-51-6 | Impurity |
| D0008-0126 | Dasatinib Impurity 89 | 1159977-13-5 | Impurity |
| D0008-0127 | Dasatinib Impurity 90 | 30273-00-8 | Impurity |
| D0008-0128 | Dasatinib Impurity 91 | 62077-27-4 | Impurity |
| D0008-0129 | Dasatinib Impurity 92 | 62077-26-3 | Impurity |
| D0008-0136 | Dasatinib Impurity 99 | 1780-26-3 | Impurity |
| D0008-0137 | Dasatinib Impurity 124 | 95-69-2 | Impurity |
| D0008-0138 | Dasatinib-13C415N2 | 1107614-42-5 | Related substance |
| D0008-0139 | DASATINIB D3 | 1132093-65-2 | Stable-isotope labelled analogue |
| D0008-0140 | Dasatinib-d4 | 1160297-08-4 | Stable-isotope labelled analogue |
| D0008-0145 | Dasatinib-d8 | 1132093-70-9 | Stable-isotope labelled analogue |
| D0008-0146 | N-Boc-N-deshydroxyethyl Dasatinib-d8 | 1263379-04-9 | Stable-isotope labelled analogue |
| D0008-0147 | N-Deshydroxyethyl Dasatinib-d8 | 1189998-96-6 | Stable-isotope labelled analogue |
| D0008-0165 | (1-Imidazo[1,2-a]pyrimidin-2-ylpropyl)amine Hydrochloride | 1609403-95-3 | Salt / salt form |
| D0008-0166 | (2S,3S,4S,5R,6R)-6-(2-(4-(6-((5-((2-Chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid | 1860069-15-3 | Related substance |
| D0008-0178 | (E)-N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide | 863127-76-8 | Related substance |
| D0008-0183 | 1-(6-((5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)-4-(2-hydroxyethyl)piperazine 1,4-dioxide | 910297-56-2 | Related substance |
| D0008-0184 | 1-(6-((5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)-4-(2-hydroxyethyl)piperazine 1-oxide | 2468737-88-2 | Related substance |
| D0008-0186 | 1-Piperazinecarboxylic-2,2,3,3,5,5,6,6-d8 acid, 4-[2-[(trimethylsilyl)oxy]ethyl]-, 1,1-dimethylethyl ester | 1160297-33-5 | Stable-isotope labelled analogue |
| D0008-0187 | 2,2'-((2-methylpyrimidine-4,6-diyl)bis(azanediyl))bis(N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide) | 2468737-80-4 | Related substance |
| D0008-0188 | 2,2'-((piperazine-1,4-diylbis(2-methylpyrimidine-6,4-diyl))bis(azanediyl))bis(N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide) | 910297-61-9 | Related substance |
| D0008-0189 | 2,2'-(piperazine-1,4-diyl)diacetonitrile | 5623-99-4 | Related substance |
| D0008-0190 | 2,2-Dimethyl-propanoic Acid [2-[[(2-Amino-5-thiazolyl)carbonyl]amino]-3-chlorophenyl]methyl Ester | 910297-69-7 | Related substance |
| D0008-0191 | 2,2-Dimethyl-propanoic Acid [3-Chloro-2-[[[2-[(triphenylmethyl)amino]-5-thiazolyl]carbonyl]amino]phenyl]methyl Ester | 910298-41-8 | Related substance |
| D0008-0195 | 2,4,6-trichloropyrimidine-5-carbaldehyde | 50270-27-4 | Related substance |
| D0008-0200 | 2-((2-hydroxyethyl)amino)acetonitrile | 54961-35-2 | Related substance |
| D0008-0203 | 2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxylic acid | 1245157-42-9 | Related substance |
| D0008-0208 | 2-((6-chloro-2-methylpyrimidin-4-yl)amino)-N-(2,6-dichlorophenyl)thiazole-5-carboxamide | 1026325-40-5 | Related substance |
| D0008-0213 | 2-(4-(6-((2-chloro-6-methylphenyl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethan-1-ol | 2099694-53-6 | Related substance |
| D0008-0215 | 2-(4-(6-((5-((2-chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethyl acetate | 1245157-85-0 | Related substance |
| D0008-0218 | 2-(bis(6-chloro-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | 1180525-74-9 | Related substance |
| D0008-0219 | 2-(piperazin-1-yl)ethan-1,1,2,2-d4-1-ol | 1160357-16-3 | Stable-isotope labelled analogue |
| D0008-0220 | 2-(Piperazin-1-yl)ethan-1-ol hydrochloride | 57938-64-4 | Salt / salt form |
| D0008-0221 | 2-(Piperazin-1-yl-2,2,3,3,5,5,6,6-d8)ethan-1-ol Hydrochloride | 1823765-30-5 | Stable-isotope labelled analogue |
| D0008-0222 | 2-(tert-Butoxycarbonylamino)thiazole-5-carboxylic Acid | 302964-02-9 | Related substance |
| D0008-0223 | 2-(trichloromethyl)pyrimidine | 54198-86-6 | Related substance |
| D0008-0224 | 2-[(2S)-1-[(1,1-diMethylethoxy)carbonyl]2-pyrrolidinyl]-4-thiazolecarboxylic acid | 251349-54-9 | Related substance |
| D0008-0228 | 2-amino-N-(2,3-dichloro-6-methylphenyl)thiazole-5-carboxamide | 2468737-78-0 | Related substance |
| D0008-0229 | 2-amino-N-(2,6-dichlorophenyl)thiazole-5-carboxamide | 1184920-49-7 | Related substance |
| D0008-0237 | 2-amino-N-(2-chloro-6-methylphenyl)oxazole-5-carboxamide | 1258411-46-9 | Related substance |
| D0008-0238 | 2-amino-N-(2-chloro-6-methylphenyl)thiazole-4-carboxamide | 1527923-10-9 | Related substance |
| D0008-0242 | 2-amino-N-(3,6-dichloro-2-methylphenyl)thiazole-5-carboxamide | 2468737-79-1 | Related substance |
| D0008-0247 | 2-amino-N-(o-tolyl)thiazole-5-carboxamide | 1184914-03-1 | Related substance |
| D0008-0249 | 2-Bromo-6-methylaniline | 53848-17-2 | Related substance |
| D0008-0250 | 2-Chloro-N-[2-chloro-6-(hydroxymethyl)phenyl]-acetamide | 910297-66-4 | Related substance |
| D0008-0251 | 2-Propenamide, 3-ethoxy-N-(2-methylphenyl)-, (2E) | 1323138-76-6 | Related substance |
| D0008-0252 | 2-Propenamide, N-(2-chloro-4-methylphenyl)-3-ethoxy | 2169776-07-0 | Related substance |
| D0008-0253 | 2-Propenamide, N-(4-chloro-2-methylphenyl)-3-ethoxy | 2169767-97-7 | Related substance |
| D0008-0257 | 4,6-dichloro-2-((6-chloro-2-methylpyrimidin-4-yl)methyl)pyrimidine | 2099694-51-4 | Related substance |
| D0008-0258 | 4,6-dichloro-2-(chloromethyl)pyrimidine | 19875-05-9 | Related substance |
| D0008-0261 | 4,6-dichloro-2-isobutyl-5-nitropyrimidine | 61456-95-9 | Isomer |
| D0008-0265 | 4-(tert-butoxy)-6-chloro-2-methylpyrimidine | 1247428-00-7 | Related substance |
| D0008-0266 | 4-acetamido-3-methylbenzenesulfonic acid, sodium salt | 102568-34-3 | Salt / salt form |
| D0008-0268 | 4-Chloro-2-methylpyrimidine | 4994-86-9 | Related substance |
| D0008-0269 | 5-Chloro Dasatinib | 2468737-75-7 | Related substance |
| D0008-0270 | 5-Thiazolecarboxamide, 2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-N-[2-methyl-6-[2-(1-piperazinyl)ethoxy]phenyl]- | 2468737-82-6 | Related substance |
| D0008-0271 | 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[(2-methyl-4-pyrimidinyl)amino]- | 823206-99-1 | Related substance |
| D0008-0272 | 5-Thiazolecarboxamide, N-[2-methyl-6-[2-(1-piperazinyl)ethoxy]phenyl]-2-[[2-methyl-6-[2-(1-piperazinyl)ethoxy]-4-pyrimidinyl]amino]- | 2468737-84-8 | Related substance |
| D0008-0273 | 5-Thiazolecarboxylic acid, 2-[(6-chloro-2-methyl-4-pyrimidinyl)amino] | 1251716-89-8 | Related substance |
| D0008-0274 | 6-chloro-N-(2-chloro-6-methylphenyl)-2-methylpyrimidin-4-amine | 1111850-50-0 | Related substance |
| D0008-0276 | Butanedioic acid, 1-[2-[4-[6-[[5-[[(2-chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazinyl]ethyl] ester | 1654008-88-4 | Related substance |
| D0008-0277 | Carbamic acid, [5-(chlorocarbonyl)-2-thiazolyl]-, 1,1-dimethylethyl ester (9CI) | 302964-20-1 | Related substance |
| D0008-0278 | Dasatinib Acetyl Impurity | 2518438-16-7 | Impurity |
| D0008-0280 | Dasatinib Ethyl Carbamate Analog | 2102305-20-2 | Related substance |
| D0008-0283 | Dasatinib Impurity | 1935225-16-3 | Impurity |
| D0008-0293 | Dasatinib-d8 N-Oxide | 1189988-36-0 | Stable-isotope labelled analogue |
| D0008-0294 | Des-2-(Piperazin-1-yl) 2-Amino Dasatinib | 302962-47-6 | Related substance |
| D0008-0295 | Des-6-[4-(2-hydroxyethyl)-1-piperazinyl]-6-chloro Dasatinib | 910297-71-1 | Related substance |
| D0008-0297 | ethyl 2-((2-chloro-6-methylphenyl)amino)-2-oxoacetate | 1349900-63-5 | Related substance |
| D0008-0301 | N-(2,3-dichloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide | 2468737-76-8 | Related substance |
| D0008-0304 | N-(2,4-dichloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide | 2468737-89-3 | Related substance |
| D0008-0306 | N-(2,6-dichlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide | 1025890-15-6 | Related substance |
| D0008-0310 | N-(2-chloro-6-methylphenyl)-2-((2-methyl-6-(piperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide hydrochloride | 1852573-26-2 | Salt / salt form |
| D0008-0317 | N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate | 863127-77-9 | Related substance |
| D0008-0318 | N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrochloride | 854001-07-3 | Salt / salt form |
| D0008-0320 | N-(2-chloro-6-methylphenyl)-2-((6-(4-formylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide | 2112837-79-1 | Related substance |
| D0008-0321 | N-(2-chloro-6-methylphenyl)-2-((6-chloropyrimidin-4-yl)amino)thiazole-5-carboxamide | 302964-27-8 | Related substance |
| D0008-0327 | N-(2-Chloro-6-methylphenyl)-2-(ethylamino)-5-thiazolecarboxamide | 1023297-24-6 | Related substance |
| D0008-0340 | N-[2-Chloro-6-(hydroxymethyl)phenyl]-2-[(triphenylmethyl)amino]-5-thiazolecarboxamide | 910297-68-6 | Related substance |
| D0008-0349 | Pyrimidine, 4,6-dichloro-2-(trichloromethyl)- | 2352-59-2 | Related substance |
| D0008-0366 | Dasatinib Impurity 115 | 48121-20-6 | Impurity |
| D0008-0368 | Dasatinib Impurity 33 | 2135905-86-9 | Impurity |